ASP Isotopes (ASPI) Gains on TerraPower Partnership for Uranium Enrichment Facility

Author's Avatar
May 19, 2025
  • ASP Isotopes Inc (ASPI, Financial) experiences significant post-market trading surge.
  • New strategic agreements with TerraPower enhance future growth prospects.
  • Analysts provide a cautious yet optimistic outlook on ASPI's price potential.

ASP Isotopes (ASPI) witnessed an impressive 11.7% increase in post-market trading, fueled by the revelation of strategic agreements with TerraPower. These pivotal deals include financing and procurement of High Assay Low-Enriched Uranium (HALEU) for an upcoming enrichment facility in South Africa, complemented by a long-term HALEU supply arrangement for TerraPower's various projects.

Analyst Price Targets and Forecast

1924586244235489280.png

Insights from two analysts provide ASP Isotopes Inc (ASPI, Financial) with a one-year average target price of $6.50. This target suggests a potential high estimate of $8.50 and a low of $4.50. These projections indicate a possible downside of 13.56% from the current trading price of $7.52. For a deeper dive into these projections, visit the ASP Isotopes Inc (ASPI) Forecast page.

Brokerage Firm Recommendations

The consensus from two brokerage firms places ASP Isotopes Inc (ASPI, Financial) with an average brokerage recommendation of 2.0, reflecting an "Outperform" status. This rating falls within a scale of 1 to 5, where 1 represents a Strong Buy and 5 indicates a Sell. Investors are encouraged to consider these recommendations when evaluating ASPI's potential.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.